Comments
Loading...
InMed Pharmaceuticals (INM) Forecast
NewsEarningsInMed Pharmaceuticals (INM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInMed Pharmaceuticals (NASDAQ:INM) Stock Quotes, Forecast and News Summary
InMed Pharmaceuticals Stock (NASDAQ: INM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy InMed Pharmaceuticals (INM) stock?
You can purchase shares of InMed Pharmaceuticals (NASDAQ:INM) through any online brokerage.
Who are InMed Pharmaceuticals (INM) competitors?
There are no as such competitors for InMed Pharmaceuticals.
What is the forecast, or price target, for InMed Pharmaceuticals (INM) stock?
InMed Pharmaceuticals has a consensus price target of $6.00.
What is the current price for InMed Pharmaceuticals (INM)?
The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $4.8319 last updated November 21, 2024 at 3:10 PM EST.
Does InMed Pharmaceuticals (INM) pay a dividend?
There are no upcoming dividends for InMed Pharmaceuticals.
When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?
InMed Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, February 11, 2025.
Is InMed Pharmaceuticals (INM) going to split?
There is no upcoming split for InMed Pharmaceuticals.
What sector and industry does InMed Pharmaceuticals (INM) operate in?
InMed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.